Treatt FY sales and profits in line with revised guidance.
Extracts and ingredients manufacturer Treatt said on Thursday that full-year revenues and profits would be in line with revised expectations.
Source: Sharecast
Treatt said FY25 revenues were set to fall to around £130.6m from £153.1m a year earlier, while pre-tax profits were expected to drop to £10.0m, down from £19.1m in FY24.
The London-listed group said trading conditions remained challenging in the second half of the year, with weaker demand in its Heritage segment due to elevated citrus oil prices, and softer North American sales amid subdued consumer confidence.
Revenue declined across all segments, with Heritage down 15%, Premium 13%, and New 17%, though the overall revenue mix remained unchanged year-on-year.
Treatt added that net debt stood at £5.9m at year-end, up from £700,000 in FY24, reflecting a £5m share buyback and ongoing cash discipline.
As of 1000 BST, Treatt shares were down 0.18% at 280.50p.
Reporting by Iain Gilbert at Sharecast.com
N/A
ISIN:
N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Chart not available
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
